Further experiments revealed that miR-147a upregulation promoted TNF-α/IFN-γ-treated keratinocyte proliferation and repressed inflammatory injury, suggesting that miR-147a upregulation might be a potential therapeutic strategy for AD. This evidence concerns the gene TNF and Alzheimer disease.